U.S. Communications Stock News

NYSE:A
NYSE:ALife Sciences

Agilent’s New FDA Approval And What It Could Mean For Investors

Agilent Technologies (NYSE:A) received FDA approval for its PD-L1 IHC 22C3 pharmDx as the only authorized companion diagnostic for certain ovarian and related cancers treated with KEYTRUDA. The approval covers use of the assay to help identify patients who may be eligible for KEYTRUDA based on PD-L1 expression. The decision expands the clinical indications for PD-L1 IHC 22C3 pharmDx within Agilent's broader oncology diagnostics portfolio. For investors, this news sits at the intersection of...
NYSE:TDC
NYSE:TDCSoftware

Does SAP’s US$480 Million Settlement Reshape the Bull Case For Teradata (TDC)?

Earlier this week, Teradata announced it had entered into a settlement agreement with SAP, under which SAP will pay US$480 million to resolve all past and pending litigation related to alleged trade secret misappropriation, leaving Teradata with an expected net cash benefit of about US$355 million to US$362 million before taxes. This settlement not only removes a major legal uncertainty but also gives Teradata additional financial flexibility at a time when its cloud ARR grew 15% and it...
NYSE:DBD
NYSE:DBDTech

Diebold Nixdorf Names New Accounting Officer As Valuation Draws Attention

Diebold Nixdorf (NYSE:DBD) has named Jeffrey Sesplankis as its principal accounting officer. Sesplankis succeeds Thomas S. Timko in this key finance and reporting role. Diebold Nixdorf, known for its ATM, payments and retail technology solutions, sits at the intersection of banking infrastructure and physical commerce. For investors, changes in senior finance roles can matter as much as product announcements, because they speak to how the company manages its books, oversees internal...
NasdaqGS:NVCR
NasdaqGS:NVCRMedical Equipment

NovoCure’s Pancreatic Cancer Approval And New CEO Shift Risk Reward Profile

NovoCure (NasdaqGS:NVCR) received FDA approval for Optune Pax in locally advanced pancreatic cancer and has started commercial launch. The approval extends the company’s Tumor Treating Fields technology beyond its historic focus in glioblastoma into a new oncology market. NovoCure also announced a new CEO and a reorganization of its clinical team alongside the launch. NovoCure now trades around $13.67, with the stock up 20.3% over the past week and 8.7% over the past month, while longer...
NYSE:TDOC
NYSE:TDOCHealthcare Services

A Look At Teladoc Health’s Valuation As 2025 Results And 2026 Outlook Refocus Attention On The Stock

Teladoc Health (TDOC) is back in focus after reporting fourth quarter and full year 2025 results, updating its 2026 outlook, and adding experienced finance executive Michael S. Smith to its board. See our latest analysis for Teladoc Health. Teladoc Health’s recent earnings update, 2026 guidance and board appointment come against a weak backdrop, with a 7 day share price return of 10.97% contrasting with a 30 day share price return of 8.36% and a 1 year total shareholder return decline of...
NasdaqGS:STGW
NasdaqGS:STGWMedia

Harris QuestRQ Launch Puts Stagwell’s Reputation Data And Valuation In Focus

Stagwell’s Harris Poll unit has launched Harris QuestRQ, an always-on reputation intelligence platform. The new tool is designed to give businesses real-time tracking of brand reputation and related insights. The launch adds a fresh product to Stagwell’s marketing and communications offering under ticker NasdaqGS:STGW. For investors watching NasdaqGS:STGW, the Harris QuestRQ launch lands at a time when the stock has been volatile, with a 23.4% decline over the past 30 days and a 25.7%...
NYSE:YUM
NYSE:YUMHospitality

Did Pizza Hut’s Tax Move and Potential Sale Just Shift Yum! Brands’ (YUM) Investment Narrative?

Yum! Brands recently reported that it paid no U.S. federal income tax on US$1.00 billion of pretax profits last year after shifting certain Pizza Hut intellectual property to Malta and is now reviewing options for its underperforming Pizza Hut division, including a potential sale and closure of about 250 weaker outlets. This reassessment comes as Taco Bell and KFC generate around 90% of Yum!’s operating profits, raising questions about how repositioning Pizza Hut could change the balance of...
NasdaqGS:SRAD
NasdaqGS:SRADHospitality

Sportradar Partnerships Deepen Betting And NBA Media Integration Potential

Sportradar Group (NasdaqGS:SRAD) expanded its partnership with Super Technologies to supply its full suite of betting solutions across regulated European markets and support entry into Brazil. The company signed a multi year agreement with NBC Sports Regional Sports Networks to power AI driven real time broadcast features for live NBA coverage. Sportradar Group, trading at $18.26, operates at the intersection of sports data, betting services, and media. The stock is up 2.8% over the past...
NYSE:NEM
NYSE:NEMMetals and Mining

Is Newmont (NEM) Pricing In Too Much Optimism After Its 208% One Year Rally

If you are wondering whether Newmont's share price still reflects its real worth after a strong run, this article will walk you through how its current price lines up with different ways of thinking about value. The stock last closed at US$130.00, with a 6.4% gain over the past 7 days, a 1.5% decline over 30 days, a 28.4% return year to date, a 208.6% return over 1 year, a 215.4% return over 3 years, and a 165.7% return over 5 years. Recent coverage around Newmont has focused on it as a...
NYSE:IVZ
NYSE:IVZCapital Markets

Is Invesco (IVZ) Stock Pricing In Too Much Optimism After Its Strong Three Year Run

If you are wondering whether Invesco's current share price really reflects its fundamentals, you are not alone. This article focuses squarely on what you might be paying for and what you are getting. Invesco's stock closed at US$26.26, with returns of 57.2% over 1 year and 68.9% over 3 years, even as the last 7 days, 30 days and year to date show declines of 0.8%, 4.7% and 2.5% respectively. Recent coverage around Invesco has focused on its position in asset management and how investors view...
NYSE:IMAX
NYSE:IMAXEntertainment

IMAX Record Box Office And Expansion Raise Questions For Investors

IMAX (NYSE:IMAX) reports a record 2025 global box office of US$1.28b. The company cites year on year growth in both revenue and operating margin for 2025. Local language films and international markets are highlighted as key content and growth drivers. IMAX expands its footprint in underpenetrated markets, including Japan, Australia, France, and Germany, with more system installations. A new partnership with Apple TV will bring live Formula 1 races into IMAX theaters. For investors watching...
NYSE:AOS
NYSE:AOSBuilding

Do A. O. Smith’s Commercial Pivot and Control Acquisitions Reshape Its Core Investment Narrative (AOS)?

In late February 2026, analysts at Goldman Sachs and Stifel updated their research on A. O. Smith, highlighting the company’s improving profitability, resilient commercial water heater and boiler performance, and mixed quarterly results alongside macro headwinds and housing-related pressures. CEO Steve Shafer’s emphasis on record EPS in 2025 and the portfolio-expanding acquisitions of Leonard Valve and Heat-Timer underscored a shift toward higher-growth, higher-margin opportunities in...
NYSE:PPL
NYSE:PPLElectric Utilities

Assessing PPL (PPL) Valuation After US$1b Offering Earnings Beat Dividend Hike And Upgraded Guidance

PPL (PPL) is in focus after completing a US$1b composite units offering and reporting fresh earnings, dividend, and guidance updates, giving investors several new data points to consider on the stock. See our latest analysis for PPL. PPL’s latest earnings, dividend increase, and US$1b composite units offering arrive after a period of steady gains, with an 11.02% year to date share price return and a 67.25% five year total shareholder return. This suggests momentum has been building rather...
NYSE:TKR
NYSE:TKRMachinery

The Bull Case For Timken (TKR) Could Change Following New Buyback And Humanoid Robotics M&A Focus

The Timken Company recently authorized a share repurchase program for up to 10,000,000 shares through February 28, 2031, while also signaling continued interest in mergers and acquisitions, including opportunities linked to humanoid robotics. By pairing a long-duration buyback plan with an active M&A agenda, Timken is emphasizing both capital return and portfolio expansion as key priorities. Next, we’ll examine how Timken’s long-term share repurchase authorization could reshape its existing...
NYSE:TWLO
NYSE:TWLOIT

Is Twilio (TWLO) Pricing Look Attractive After Mixed Multi Year Share Performance

If you are wondering whether Twilio shares are attractively priced or still carry too much risk, you are not alone. This article is designed to help you make sense of where the current valuation sits. Twilio last closed at US$120.96, with a 6.9% return over the past week, an 11.0% decline over the past month, and year to date and 1 year returns of a 12.6% decline and 0.9% respectively, alongside a 63.7% gain over 3 years and a 64.1% decline over 5 years. These mixed returns sit against a...
NYSE:ARX
NYSE:ARXInsurance

Accelerant Refreshes Legal And Investor Relations Leadership As Story Evolves

Accelerant Holdings (NYSE:ARX) appointed Cliff Jenks as General Counsel and Corporate Secretary, succeeding founding executive Nancy Hasley, who is retiring. The company also created a new Head of Investor Relations role, naming Ray Iardella to lead engagement with shareholders and the market. These leadership changes focus on legal governance and investor communications, two areas that are central to how the company presents itself to public markets. Accelerant Holdings, trading at around...
NYSE:SMA
NYSE:SMASpecialized REITs

Assessing SmartStop Self Storage REIT (SMA) Valuation After Recent Share Price Momentum

Why SmartStop Self Storage REIT is on investors’ radar today SmartStop Self Storage REIT (SMA) has drawn attention after recent share price moves, with the stock up around 7% over the past month and roughly 2% over the past 3 months. See our latest analysis for SmartStop Self Storage REIT. At a share price of US$33.35, SmartStop Self Storage REIT has a 1 day share price return of 1.06%. Its 30 day and year to date share price returns of 7.10% and 8.42% suggest momentum has been building...
NYSE:VSH
NYSE:VSHElectronic

What Vishay Intertechnology (VSH)'s New VOx619A Energy‑Efficient Optocouplers Mean For Shareholders

In February 2026, Vishay Intertechnology introduced its VOx619A phototransistor optocoupler series, featuring low 0.5 mA forward current, high linear current transfer ratio over temperature, and operation up to +125 °C across four isolation-focused package options for industrial, telecom, and consumer uses. The combination of higher temperature tolerance, more consistent signal transfer, and lower power consumption positions these optocouplers as a way to support more efficient,...
NasdaqGS:NTRA
NasdaqGS:NTRABiotechs

Natera (NTRA) Q4 Profit Sparks Questions Around Bullish Earnings Turnaround Narrative

Natera (NTRA) just closed out FY 2025 with fourth quarter revenue of US$665.5 million and basic EPS of US$0.34, alongside trailing twelve month revenue of about US$2.3 billion and a TTM basic EPS loss of US$1.52. The company has seen quarterly revenue move from US$476.1 million in Q4 2024 to US$665.5 million in Q4 2025, while quarterly basic EPS shifted from a loss of US$0.41 in Q4 2024 to EPS of US$0.34 in Q4 2025. This sets up a results season where investors are focused squarely on how...
NYSE:BKSY
NYSE:BKSYProfessional Services

BlackSky Technology (BKSY) Deepens Rocket Lab Ties and Grows Gen-3 Backlog Is Its Moat Emerging?

In February 2026, Rocket Lab USA announced a new multi-launch agreement with BlackSky Technology, adding four dedicated Electron missions to deploy BlackSky’s AI-enabled Gen-3 Earth observation satellites and bringing their total launches together to 17 since 2019. BlackSky also reported fourth-quarter 2025 results showing year-over-year revenue growth to US$35.21 million and a sharply reduced quarterly net loss to US$0.87 million, alongside fresh 2026 revenue guidance and sizeable new Gen-3...
NasdaqGS:AMZN
NasdaqGS:AMZNMultiline Retail

Reassessing Amazon.com (AMZN) After 121% Three Year Rally And Recent Share Price Pullback

If you are wondering whether Amazon.com is still a reasonable entry at around US$209.97, the key question is whether the current price reflects its underlying business value. After a 121.3% return over 3 years but a 13.6% decline over the past 30 days and a 7.3% decline year to date, some investors are reassessing both the growth potential and the level of risk they are taking on with Amazon.com. Recent news flow around Amazon.com has continued to focus on its role as a large e commerce and...
NYSE:ARW
NYSE:ARWElectronic

Arrow Electronics Taps NomAIzo To Push Deeper Into Edge To Cloud AI

eInfochips, a subsidiary of Arrow Electronics (NYSE:ARW), has launched NomAIzo, a suite of AI-focused platforms, frameworks, and services. NomAIzo is designed to help customers accelerate edge to enterprise AI adoption across use cases from devices to the cloud. The launch expands Arrow Electronics' presence in AI and high tech engineering services by broadening its edge to cloud offering. For you as an investor, NomAIzo ties directly into what Arrow Electronics already does across...
NasdaqGS:LAMR
NasdaqGS:LAMRSpecialized REITs

How Lamar’s Expanded Buyback and Dividend Plans Will Impact Lamar Advertising (LAMR) Investors

Lamar Advertising recently declared a past quarterly cash dividend of US$1.60 per share, payable on March 31, 2026, and extended its stock and debt repurchase programs, each authorizing up to US$250.00 million through September 30, 2027. These moves highlight management’s focus on returning capital to shareholders while signaling confidence in the company’s balance sheet and cash-generation capacity. Now we’ll examine how the extended stock repurchase authorization influences Lamar’s...
NasdaqGM:RLAY
NasdaqGM:RLAYBiotechs

Relay Therapeutics (RLAY) Losses Of US$276.5 Million Test Bullish Revenue Growth Narrative

Relay Therapeutics FY 2025 earnings: revenue modest, losses continue as investors focus on growth potential Relay Therapeutics (RLAY) has wrapped up FY 2025 with Q4 revenue of US$7 million, a basic EPS loss of US$0.32, and net income loss of US$54.89 million, keeping the story firmly in loss-making territory as the market weighs its growth profile. The company has seen quarterly revenue move between US$0 million and US$7.68 million over the past year, while basic EPS losses have ranged from...